{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:55:04Z","timestamp":1759341304221},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.lpm.2013.08.006","type":"journal-article","created":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T09:30:44Z","timestamp":1395135044000},"page":"510-519","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Macrolides au long cours et pathologie bronchique chronique de l\u2019adulte\u00a0: int\u00e9r\u00eats et limites"],"prefix":"10.1016","volume":"43","author":[{"given":"St\u00e9phane","family":"Jouneau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beno\u00eet","family":"Desrues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2013.08.006_bib0005","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00228-011-1161-x","article-title":"from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases","volume":"68","author":"Zarogoulidis","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.lpm.2013.08.006_bib0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1183\/09031936.00136712","article-title":"Long-term macrolide treatment for chronic respiratory disease","volume":"42","author":"Spagnolo","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2013.08.006_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007716.pub3","article-title":"Macrolides for diffuse panbronchiolitis","volume":"2","author":"Yang","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2013.08.006_bib0020","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","article-title":"Azithromycin in patients with cystic fibrosis chronically infected with pseudomonas aeruginosa","volume":"290","author":"Saiman","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2013.08.006_bib0025","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1183\/09031936.00208011","article-title":"Macrolide effects on the prevention of COPD exacerbations","volume":"40","author":"Yamaya","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2013.08.006_bib0030","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMra032424","article-title":"Drug metabolism and variability among patients in drug response","volume":"352","author":"Wilkinson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2013.08.006_bib0035","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/AAC.50.5.1680-1688.2006","article-title":"Quorum-sensing antagonistic activities of azithromycin in pseudomonas aeruginosa PAO1: a global approach","volume":"50","author":"Nalca","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lpm.2013.08.006_bib0040","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/CMR.00078-09","article-title":"Mechanisms of action and clinical application of macrolides as immunomodulatory medications","volume":"23","author":"Kanoh","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.lpm.2013.08.006_bib0045","doi-asserted-by":"crossref","first-page":"649570","DOI":"10.1155\/2012\/649570","article-title":"Macrolide therapy in respiratory viral infections","volume":"2012","author":"Min","year":"2012","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.lpm.2013.08.006_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/37.suppl_C.1","article-title":"Azithromycin-review of key chemical, pharmacokinetic and microbiological features","volume":"37","author":"Lode","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.lpm.2013.08.006_bib0055","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/thorax.57.8.672","article-title":"Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment","volume":"57","author":"Blasi","year":"2002","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.lpm.2013.08.006_bib0060","doi-asserted-by":"crossref","first-page":"e35945","DOI":"10.1371\/journal.pone.0035945","article-title":"Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity","volume":"7","author":"Hahn","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.lpm.2013.08.006_bib0065","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1086\/511076","article-title":"Acute respiratory infection due to Chlamydia pneumonia: current status of diagnostic methods","volume":"44","author":"Kumar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2013.08.006_bib0070","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002997.pub2","article-title":"Macrolides for chronic asthma","volume":"4","author":"Richeldi","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2013.08.006_bib0075","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/thoraxjnl-2012-202698","article-title":"Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a mluticentre randomised double-blind placebo-controlled trial","volume":"68","author":"Brusselle","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.lpm.2013.08.006_bib0080","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jaci.2010.07.024","article-title":"A trial of clarithromycin for the treatment of suboptimally controlled asthma","volume":"126","author":"Rand Sutherland","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.lpm.2013.08.006_bib0085","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1465-9921-9-48","article-title":"Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumonia infection","volume":"9","author":"Cosentini","year":"2008","journal-title":"Respir Res"},{"key":"10.1016\/j.lpm.2013.08.006_bib0090","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/rccm.200707-1134OC","article-title":"Clarithromycin targets neutrophilic airway inflammation in refractory asthma","volume":"177","author":"Simpson","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2013.08.006_bib0095","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomized, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2013.08.006_bib0100","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2013.2290","article-title":"Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis. The BLESS randomized controlled trial","volume":"309","author":"Serisier","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2013.08.006_bib0105","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis. The BAT randomized controlled trial","volume":"309","author":"Altenburg","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2013.08.006_bib0110","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200801-145OC","article-title":"Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations","volume":"178","author":"Seemungal","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2013.08.006_bib0115","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2013.08.006_bib0120","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMct1115170","article-title":"Antibiotic prevention of acute exacerbation of COPD","volume":"367","author":"Wenzel","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2013.08.006_bib0125","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.rmed.2012.12.019","article-title":"Preventing COPD exacerbations with macrolides: a review and budget impact analysis","volume":"107","author":"Simoens","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.lpm.2013.08.006_bib0130","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1183\/09031936.00068310","article-title":"A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation","volume":"37","author":"Vos","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2013.08.006_bib0135","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000341982","article-title":"Clarithromycin stops lung function decline in airway-centered interstitial fibrosis","volume":"85","author":"Jouneau","year":"2013","journal-title":"Respiration"},{"key":"10.1016\/j.lpm.2013.08.006_bib0140","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/clpt.2009.127","article-title":"Macrolide-induced digoxin toxicity: a population-based study","volume":"86","author":"Gomes","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.lpm.2013.08.006_bib0145","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa040582","article-title":"Oral erythromycin and the risk of sudden death from cardiac causes","volume":"351","author":"Ray","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2013.08.006_bib0150","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Ray","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2013.08.006_bib0155","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMoa1300799","article-title":"Use of azithromycin and death from cardiovascular causes","volume":"368","author":"Svanstr\u00f6m","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2013.08.006_bib0160","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa043526","article-title":"Azithromycin for the secondary prevention of coronary events","volume":"352","author":"Grayston","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2013.08.006_bib0165","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/000348940010900416","article-title":"Irreversible sensorineural hearing loss as a result of azithromycin ototoxicity","volume":"109","author":"Ress","year":"2000","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.lpm.2013.08.006_bib0170","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(07)60235-9","article-title":"Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomized, double-blind, placebo-controlled study","volume":"369","author":"Malhotra-Kumar","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2013.08.006_bib0175","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/INF.0b013e318247f3e0","article-title":"Rising rates of macrolide-resistant Mycoplasma pneumonia in the central United States","volume":"31","author":"Yamada","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.lpm.2013.08.006_bib0180","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/INF.0b013e31819e3f7a","article-title":"Emerging macrolide resistance in mycoplasma pneumoniae in children: detection and characterization of resistant isolates","volume":"28","author":"Li","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.lpm.2013.08.006_bib0185","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.inf.0000247109.44249.ac","article-title":"Maintenance azithromycin treatment in pediatric patients with cystic fibrosis","volume":"26","author":"Tramper-Stranders","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.lpm.2013.08.006_bib0190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcf.2012.05.010","article-title":"A retrospective analysis of the impact of azithromycin maintenance therapy on adults attending a UK cystic fibrosis clinic","volume":"12","author":"Fleet","year":"2013","journal-title":"J Cyst Fibros"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498214000992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498214000992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T01:23:07Z","timestamp":1538788987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498214000992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0755498214000992"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2013.08.006","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrolides au long cours et pathologie bronchique chronique de l\u2019adulte\u00a0: int\u00e9r\u00eats et limites","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2013.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}